Laura Muñoz‐Moreno

415 total citations
34 papers, 323 citations indexed

About

Laura Muñoz‐Moreno is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Laura Muñoz‐Moreno has authored 34 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in Laura Muñoz‐Moreno's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Metal complexes synthesis and properties (7 papers) and Dendrimers and Hyperbranched Polymers (6 papers). Laura Muñoz‐Moreno is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Metal complexes synthesis and properties (7 papers) and Dendrimers and Hyperbranched Polymers (6 papers). Laura Muñoz‐Moreno collaborates with scholars based in Spain, United States and Italy. Laura Muñoz‐Moreno's co-authors include Marı́a J. Carmena, Ana M. Bajo, Andrew V. Schally, Juan Carlos Prieto, Tomás Cuenca, Eva Royo, Juan Carlos Prieto, Marı́a Luisa Marina, M. Isabel Arenas and María Concepción García and has published in prestigious journals such as Chemistry of Materials, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Laura Muñoz‐Moreno

31 papers receiving 316 citations

Peers

Laura Muñoz‐Moreno
Jung Eun Kim South Korea
Laura Muñoz‐Moreno
Citations per year, relative to Laura Muñoz‐Moreno Laura Muñoz‐Moreno (= 1×) peers Jung Eun Kim

Countries citing papers authored by Laura Muñoz‐Moreno

Since Specialization
Citations

This map shows the geographic impact of Laura Muñoz‐Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Muñoz‐Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Muñoz‐Moreno more than expected).

Fields of papers citing papers by Laura Muñoz‐Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Muñoz‐Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Muñoz‐Moreno. The network helps show where Laura Muñoz‐Moreno may publish in the future.

Co-authorship network of co-authors of Laura Muñoz‐Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Muñoz‐Moreno. A scholar is included among the top collaborators of Laura Muñoz‐Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Muñoz‐Moreno. Laura Muñoz‐Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Yang, Uwe Lappan, Susanne Boye, et al.. (2025). Biological activation of Fenton reaction in polymeric nanoreactors driven by ferrocene-containing membranes: a microenvironment dependent study. Journal of Materials Chemistry B. 13(6). 1980–1990. 1 indexed citations
3.
Muñoz‐Moreno, Laura, et al.. (2025). Fundamentals of Zymography: Applications to the Study of Biological Samples. Methods in molecular biology. 2918. 37–46.
4.
Muñoz‐Moreno, Laura, et al.. (2024). Study of the microRNA fraction in food waste and other biomasses. Assessment of its antioxidant and anti-inflammatory activity. Journal of Functional Foods. 119. 106347–106347. 1 indexed citations
5.
Muñoz‐Moreno, Laura, et al.. (2024). Cationic Carbosilane Dendrimers for Apmnkq2 Aptamer Transfection in Breast Cancer: An Alternative to Traditional Transfectants.. Macromolecular Bioscience. 25(1). e2400327–e2400327. 1 indexed citations
6.
Muñoz‐Moreno, Laura, et al.. (2024). Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study. International Journal of Molecular Sciences. 25(6). 3345–3345. 3 indexed citations
7.
Muñoz‐Moreno, Laura, M. Isabel Arenas, Marı́a J. Carmena, et al.. (2024). Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers. International Journal of Molecular Sciences. 25(20). 11200–11200. 1 indexed citations
8.
Muñoz‐Moreno, Laura, et al.. (2023). Induction of more aggressive tumoral phenotypes in LNCaP and PC3 cells by serum exosomes from prostate cancer patients. International Journal of Cancer. 153(10). 1829–1841. 2 indexed citations
9.
Muñoz‐Moreno, Laura, et al.. (2023). Amphiphilic Dendritic Hydrogels with Carbosilane Nanodomains: Preparation and Characterization as Drug Delivery Systems. Chemistry of Materials. 35(7). 2797–2807. 11 indexed citations
10.
Muñoz‐Moreno, Laura, et al.. (2023). Carbohydrate effect of novel arene Ru(II) phenanthroline-glycoconjugates on metastatic biological processes. Journal of Inorganic Biochemistry. 247. 112326–112326. 5 indexed citations
12.
Muñoz‐Moreno, Laura, Marı́a J. Carmena, Andrew V. Schally, Juan Carlos Prieto, & Ana M. Bajo. (2019). Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists. Investigational New Drugs. 38(3). 746–754. 14 indexed citations
13.
Muñoz‐Moreno, Laura, Adrián Pérez‐Redondo, Ana M. Bajo, et al.. (2018). Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands. Journal of Inorganic Biochemistry. 183. 32–42. 12 indexed citations
14.
Muñoz‐Moreno, Laura, Ana M. Bajo, Juan Carlos Prieto, & Marı́a J. Carmena. (2017). Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells. Molecular and Cellular Endocrinology. 446. 59–69. 16 indexed citations
15.
Muñoz‐Moreno, Laura, Pedro L. Valenzuela, Juan Carlos Prieto, et al.. (2016). Growth hormone-releasing hormone induced transactivation of epidermal growth factor receptor in human triple-negative breast cancer cells. Peptides. 86. 153–161. 4 indexed citations
16.
Muñoz‐Moreno, Laura, Benelita T. Elie, Marta E. G. Mosquera, et al.. (2015). Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents. Journal of Inorganic Biochemistry. 156. 22–34. 14 indexed citations
17.
Muñoz‐Moreno, Laura, M. Isabel Arenas, Marı́a J. Carmena, et al.. (2014). Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models. Investigational New Drugs. 32(5). 871–882. 18 indexed citations
18.
Arenas, M. Isabel, Laura Muñoz‐Moreno, Ana M. Bajo, et al.. (2013). Antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice. Cancer Letters. 336(1). 196–203. 10 indexed citations
19.
Muñoz‐Moreno, Laura, M. Isabel Arenas, Andrew V. Schally, et al.. (2012). Inhibitory effects of antagonists of growth hormone‐releasing hormone on growth and invasiveness of PC3 human prostate cancer. International Journal of Cancer. 132(4). 755–765. 18 indexed citations
20.
Sotomayor, Sandra, Laura Muñoz‐Moreno, Marı́a J. Carmena, et al.. (2010). Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN‐215) and a bombesin antagonist (RC‐3095). International Journal of Cancer. 127(8). 1813–1822. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026